Kestra Advisory Services’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Buy |
40,720
+1,820
| +5% | +$4.81K | ﹤0.01% | 2724 |
|
|
2025
Q1 | $117K | Buy |
38,900
+1,880
| +5% | +$5.66K | ﹤0.01% | 2568 |
|
|
2024
Q4 | $94.8K | Buy |
37,020
+3,970
| +12% | +$10.2K | ﹤0.01% | 2564 |
|
|
2024
Q3 | $123K | Sell |
33,050
-970
| -3% | -$3.61K | ﹤0.01% | 2431 |
|
|
2024
Q2 | $215K | Buy |
34,020
+1,200
| +4% | +$7.58K | ﹤0.01% | 2353 |
|
|
2024
Q1 | $176K | Buy |
32,820
+6,020
| +22% | +$32.3K | ﹤0.01% | 2307 |
|
|
2023
Q4 | $135K | Buy |
26,800
+3,500
| +15% | +$17.6K | ﹤0.01% | 2168 |
|
|
2023
Q3 | $39.4K | Sell |
23,300
-3,400
| -13% | -$5.75K | ﹤0.01% | 2070 |
|
|
2023
Q2 | $74.2K | Buy |
+26,700
| New | +$74.2K | ﹤0.01% | 2023 |
|